当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 资产负债表

凯普生物

(300639)

  

流通市值:38.75亿  总市值:39.44亿
流通股本:6.35亿   总股本:6.47亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金788,454,632.85775,746,540.56932,450,807.461,024,775,861.2
应收票据及应收账款2,259,285,756.982,402,960,172.032,440,343,362.132,725,397,067.98
其中:应收票据2,283,621.763,253,565.63,049,7303,869,228.05
应收账款2,257,002,135.222,399,706,606.432,437,293,632.132,721,527,839.93
预付款项20,444,838.7818,245,468.3124,663,814.9619,293,982.92
其他应收款合计20,356,217.0224,019,701.7816,596,579.3216,324,527.57
应收股利-5,168,800--
存货120,773,726.97121,430,373.9107,683,973.22118,738,663.76
其他流动资产118,542,573.62121,603,199.09128,308,186.77108,691,019.37
流动资产平衡项目0000
流动资产合计3,604,905,522.183,729,306,570.814,023,150,407.64,400,277,632
非流动资产:
长期股权投资30,180,969.2830,142,137.4130,273,154.3130,849,876.49
其他权益工具投资288,737,005.58282,846,711.45283,003,440.82277,127,113.35
其他非流动金融资产214,000,000214,000,000214,000,000214,000,000
固定资产1,269,586,616.891,276,515,299.071,246,189,227.131,220,481,378.53
在建工程132,136,168.1697,141,206.52102,356,893.558,624,580.9
使用权资产27,122,855.6429,793,479.8733,813,399.4337,852,820.44
无形资产246,178,075.16245,937,767.93235,733,454.25185,208,237.52
开发支出30,041,058.3428,616,769.6735,582,236.7533,558,958.9
长期待摊费用46,584,662.5950,227,207.6347,966,222.6748,051,764.75
递延所得税资产185,749,787.53155,669,565.92163,785,062.19170,200,981.78
其他非流动资产19,921,233.2929,854,443.625,911,904.7654,892,498.55
非流动资产平衡项目0000
非流动资产合计2,490,238,432.462,440,744,589.072,418,614,995.812,330,848,211.21
资产平衡项目0000
资产总计6,095,143,954.646,170,051,159.886,441,765,403.416,731,125,843.21
流动负债:
短期借款66,390,147.96100,106,833.32100,180,999.9998,484,458.64
应付票据及应付账款168,677,135.44251,130,835.92335,377,364.04466,689,877.79
应付账款168,677,135.44251,130,835.92335,377,364.04466,689,877.79
合同负债16,626,559.7219,111,582.0116,938,488.5322,156,062.06
应付职工薪酬106,244,604.0298,918,242.3799,558,173.64181,831,912.8
应交税费267,229,677.88269,223,200.56304,685,848.86371,218,689.17
其他应付款合计155,961,952.22139,720,511.09190,340,396.46210,611,484.04
应付股利8,274,630.93---
一年内到期的非流动负债7,062,370.567,059,983.289,339,260.9610,475,652.21
其他流动负债898,894.781,060,215.13,969,506.541,363,951.02
流动负债平衡项目0000
流动负债合计789,091,342.58886,331,403.651,060,390,039.021,362,832,087.73
非流动负债:
长期借款20,012,833.3510,008,888.89--
租赁负债24,820,980.7127,364,576.828,308,770.7430,534,526.13
递延收益12,089,769.3412,770,475.2313,451,180.8314,131,886.63
递延所得税负债91,792,900.8693,387,931.2295,084,689.3896,743,233.78
非流动负债平衡项目0000
非流动负债合计148,716,484.26143,531,872.14136,844,640.95141,409,646.54
负债平衡项目0000
负债合计937,807,826.841,029,863,275.791,197,234,679.971,504,241,734.27
所有者权益(或股东权益):
实收资本(或股本)649,149,874649,149,874439,516,016439,516,016
资本公积875,102,345.24878,104,365.161,191,272,455.911,190,011,899.48
减:库存股100,000,734.93100,000,734.93153,003,114.92149,989,053.55
其他综合收益189,823,338.45194,677,238.89142,780,793.02169,838,437.24
盈余公积56,672,097.9956,672,097.9956,672,097.9956,672,097.99
未分配利润3,212,705,900.513,169,434,079.993,265,871,925.733,200,518,049.11
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,883,452,821.264,848,036,921.14,943,110,173.734,906,567,446.27
少数股东权益273,883,306.54292,150,962.99301,420,549.71320,316,662.67
股东权益平衡项目0000
股东权益合计5,157,336,127.85,140,187,884.095,244,530,723.445,226,884,108.94
负债和股东权益合计6,095,143,954.646,170,051,159.886,441,765,403.416,731,125,843.21
公告日期2023-10-262023-08-312023-04-252023-04-15
审计意见(境内)标准无保留意见
TOP↑